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Abstract
Context and Objective: The etiology of miscarriage is often multifactorial. One major cause, immunological rejection of the
fetus, has not been clearly elucidated. Our aim was to establish whether the semaphorin CD100, its natural receptor CD72,
and the glycoprotein CD45, implicated in immune mechanisms, are involved in pregnancy loss by examining their placental
expression with real-time PCR, immunohistochemistry and western blotting techniques.
Patients: Placenta tissue from 72 Caucasian women undergoing surgical uterine evacuation due to early spontaneous
pregnancy loss between the 8
th and 12
th week of gestation was divided into four groups based on miscarriage number.
Gestational age-matched placentas from 18 healthy women without a history of miscarriage undergoing voluntary
pregnancy termination were the control group. Placenta from 6 Caesarean deliveries performed at 38–40 weeks of gestation
was also studied.
Results: CD100, CD72 and CD45 were expressed in placenta and exhibited different mRNA and protein levels in normal
pregnancy and miscarriage. In particular, protein levels were highly dysregulated around 10 weeks of gestation in first and
second miscarriage placentas. The CD100 soluble form was produced and immediately shed from placental tissue in all
samples.
Conclusions: Fetal CD100, CD72 and CD45 seem to play a role in miscarriage. The present data support the involvement of
the fetal immune system in pregnancy maintenance as well as failure.
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Introduction
Miscarriage (fetal death before 24 weeks of gestation, w.g.) is
a frequent event in human pregnancy. Indeed as many as one
in five clinical pregnancies results in miscarriage [1]; recurrent
miscarriage (three or more consecutive miscarriages) accounts
for > 10% of all cases. The etiology of miscarriage is often
multifactorial; established risk factors include parental chromo-
somal and uterine anatomical abnormalities [2], advanced
maternal age [3], a history of miscarriage [4], and infertility
[5]. Several behavioral and social risk factors, such as alcohol
[6] and caffeine consumption [7,8] and cigarette smoking [7],
have been reported to increase the risk. An additional cause is
immunological rejection of the fetus due to disruption of the
mechanisms that normally prevent maternal immune system
activation by the paternal antigens expressed by the developing
fetus [9]. In a normal pregnancy the maternal immune system
is not suppressed; on the contrary, it is capable of efficiently
recognizing and reacting against foreign antigens of the ‘‘fetal
transplant’’ [10]. The goal of the maternal response is to avoid
extravillous trophoblast cell over-invasion [11], balancing womb
integrity and fetal nutrition [12]. Such balance is realized by the
development by maternal leukocytes of tolerance for the
antigens expressed in the semi-allogeneic/allogeneic fetal cells.
Specific fetal mechanisms also provide for acceptance of the
mother’s cells, since some cell surface characteristics are not
inherited [13]. Shao L. et al. [14] noted that human placental
trophoblasts activate a particular type of T cells that modulate
T cell-dependent B cell responses, resulting in efficient
suppression of Ig secretion. A further insight into the
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recent discovery of a mechanism by which the mother trains the
fetus’s budding immune system: the mother’s foreign antigens
cross the placenta [15,16] to lodge in fetal lymph nodes, which
are populated by T cells as early as 10 w.g. [17], inducing
development of antigen-specific Tregs that suppress antimaternal
immunity and persist at least until early adulthood [18].
However, the fetal mechanisms that circumvent the maternal
immune response in the pregnant uterus are still unclear.
Semaphorins are transmembrane proteins implicated in many
processes including neural development [19], tumor progression
[20], and cardiovascular development [21]. Recently, several
roles for semaphorins have been identified in the immune
system [22]; 4D (CD100), the first semaphorin to be found and
characterized in the immune system, is sometimes cleaved from
the cell surface to release a soluble semaphorin [23]. CD100 is
constitutively expressed on T cells, where it is up-regulated as a
result of T cell activation [24]; it is also expressed, albeit to a
lesser extent, on macrophages, B cells, natural killer (NK) cells
and neutrophils [24]. CD100 acts on immune cells–such as B
cells and dendritic cells (DCs)–through CD72, its main receptor
in lymphoid tissue [25,26]. CD72 is a well-known B cell antigen
expressed on the surface of antigen-presenting cells (APCs),
mainly B cells and, to a lesser extent, DCs and macrophages
[24,27]. It seems to function as a negative regulator of immune
cell responses [25,26]. CD100 induces tyrosine dephosphoryla-
tion of the CD72 cytoplasmic domain, turning off its inhibitory
signaling and enhancing immune cell responses [25,26]. CD100
is physically associated to the transmembrane glycoprotein
CD45 (common leukocyte antigen), an association that becomes
closer during immune cell activation [28,29]. In addition, CD45
triggers generation of the soluble form of CD100 which,
similarly to other diffusible factors, augments the immune
response by acting on remote immune cells [30].
Given the active role of CD100, CD72 and CD45 in
immune response modulation and the growing interest in the
immunological causes of spontaneous miscarriage, we investi-
gated for the first time whether these molecules are expressed in
placental tissue and whether they could be involved in
pregnancy loss. Real-time PCR, immunohistochemistry and
quantitative western blotting techniques allowed documenting
significant dysregulation in their expression in miscarriage tissue,
supporting the potential involvement of the fetal immune system
in pregnancy maintenance as well as failure.
Materials and Methods
Ethics Statement
All patients provided their informed consent to participate in
the study, which was approved by the Ethics Committee of
Universita ` Politecnica delle Marche. We used placenta and tonsil
tissue collected in surgical bins for disposal as rubbish. Since the
tissues did not require histopathological examination and the study
did not expose subjects to any risk, an oral authorization in lieu of
a written consent was obtained from patients and from children’s
parents (Department of Clinical Sciences, 8/1 February 2009). A
verbal consent form, one per patient, reporting the study
summary; the subject’s comprehension and ability to consent;
voluntariness (freedom from coercion or undue influence, real or
imagined); and the opportunity to ask questions and consider their
decision was signed and dated by the operator (T.L.) to document
the donor’s verbal authorization and filed in the Department
archives.
A power analysis was performed to establish how many cases
were needed. The methods used to achieve the study aims were
documented. A data collection procedure was devised to obtain an
anonymous database ensuring blind sample-result correlation and
standardization.
Sample Types and Tissue Processing
Placental tissue was obtained during surgical uterine evacuation
from women with early spontaneous pregnancy loss, defined as
miscarriage, between the 8
th and 12
th w.g., the period when the
fetal immune system begins to develop. Gestational age (GA) was
calculated from the last menstrual period. Patients were evaluated
by ultrasonography (US) when they presented with vaginal
bleeding. Uterine evacuation was performed within 24 h of US
documentation of fetal death.
All women undergoing surgical uterine evacuation due to
miscarriage at the Unit of Obstetrics and Gynecology, ‘‘G. Salesi’’
Hospital, Ancona, from February 2008 to December 2010, were
invited to participate. Exclusion criteria were antiphospholipid
syndrome, endocrine disorders, infection, chromosomal aberra-
tions, uterine structure abnormality, cigarette smoking, use of
cocaine or alcohol and caffeine overuse.
A total of 72 women (mean age 35.7 years, range 28–44) were
enrolled and divided into first, second, third and fourth
miscarriage; all had had singleton pregnancies. The control group
included GA-matched placental tissue from 18 healthy women
without a history of miscarriage, who underwent termination of
pregnancy in the first trimester for psychological or social reasons.
Table 1. Characteristics of the primers used for SYBR green Q-PCR assays.
Target gene Primer
a Primer sequence (59–39) Tm (6C)
b %G C
Amplicon
length (bp) Accession no.
Human CD100 hCD100_F hCD100_R GAGAAGCAGCATGAGGTGTA
ATGACGGATGTGTAGCTGTG
57,3 57,3 50 50 266 NM_006378 NM_001142287
Human CD72 hCD72_F hCD72_R CTGAGCAACATGGAGAACAG
GCATAAGTCCTAGTGCGTTG
57,3 57,3 50 50 323 NM_001782
Human CD45 hCD45_F hCD45_R CTGACATCATCACCTAGCAG
TGCTGTAGTCAATCCAGTGG
57,3 57,3 50 50 257 NM_002838 NM_080921
NM_080922 NM_080923
Human SDHA hSDHA_F hSDHA_R AGCATCGAAGAGTCATGCAG
TCAATCCGCACCTTGTAGTC
57,3 57,3 50 50 398 NM_004168
aThe letters F and R at the end of the primer name indicate forward and reverse orientations, respectively.
bTheoretical melting temperature (Tm) calculated using the MWG Oligo Property Scan (MOPS).
doi:10.1371/journal.pone.0035232.t001
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tissue samples were subdivided into 3 w.g. subgroups (8# w.g. ,9;
9# w.g. #10; and w.g. .10), each containing 6 specimens.
Finally, we studied normal term placenta from 6 Caesarean
deliveries performed at 38–40 w.g. The mean age of these subjects
was 34 years (range 31–40). All subjects were Caucasian.
Tonsils from children undergoing tonsillectomy were used as
a positive control [30,31,32]. Two randomly selected samples
from each placenta and tonsil specimen were washed with
saline; one was frozen in liquid nitrogen within 5 min and
stored at 2 80uC until use for molecular and biochemical
analysis, the other was fixed for 24 h in 4% neutral buffered
formalin at 4uC and embedded in paraffin for immunohisto-
chemistry.
Preparation of cDNA for Real-time PCR
Total RNA was extracted from 10 mg of frozen placenta and
tonsil using the Total RNA purification kit and then cleaned up
and concentrated using the CleanAll RNA/DNA Clean-Up and
Concentration kit (both from Norgen, Biotek Corp., Thorold,
Ontario, Canada) according to the manufacturer’s instructions.
The quality (A260/A280) and quantity (A260) of extracted RNA
were tested with a NanoDropH ND-1000 UV-Vis Spectropho-
tometer (Celbio, Milan, Italy) and 1 mg of RNA was reverse
transcribed using the high-capacity cDNA RT kit (Applied
Biosystems, Foster City, CA, USA) in a total volume of 20 ml
using random primers.
Real-time PCR
The sequences of the real-time PCR (Q-PCR) primers
targeting CD100, CD72 and CD45 genes, comprising known
transcript variants (2 variants for CD100 and 4 variants for
CD45) are summarized in Table 1. SDHA (succinate dehydro-
genase complex subunit A) was used as the housekeeping gene
for data normalization, to correct for variations in RNA quality
and quantity. Q-PCR was performed in a reaction mixture
containing 10 ml of 2X iQ SYBR Green Supermix (Bio-Rad
Laboratories, Milan, Italy), 0.1 mM of each primer, 15 ng of
sample template and RNase-free sterile water to reach a final
volume of 20 ml. Amplification was performed using the iQ5
Multicolor Real-Time PCR Detection System (Bio-Rad Labo-
ratories) as follows: i) an initial denaturation step at 95uC for
15 min; ii) 45 cycles, with 1 cycle consisting of denaturation at
95uC for 10 s, annealing at 60uC for 30 s and extension at
72uC for 30 s. Q-PCR assays with CT values .40 were
considered negative. For each PCR run, a negative (no
template) control was used to test for false-positive results or
contamination. The absence of non-specific products or primer
dimers was confirmed by the observation of a single melting
peak in melting curve analysis. For each Q-PCR assay, genes
were run in duplicate and all samples tested in three separate
experiments. In addition, the standard curve for each gene was
constructed using serial dilutions of the cDNA obtained from
the tonsil sample. Since PCR efficiencies were close to 100%,
the 2
-DDCt (Livak) method was used to compare data from
miscarriage and term placentas to normal first trimester
placentas (control group). The results were expressed as ‘‘fold
changes’’ in relative gene expression compared to the control
group.
Immunohistochemistry
Each paraffin-embedded placenta and tonsil sample was cut
into 3 mm serial sections that were then deparaffinized and
rehydrated through xylene and a graded series of ethyl alcohol.
The first section was stained with hematoxylin-eosin for
morphological examination. To inhibit endogenous peroxidase
activity, sections were incubated for 30 min with 3% hydrogen
peroxide in deionized water. Then, they were washed in 50 mM
Tris/HCl, pH 7.6 and pretreated at 98uC in 10 mM sodium
citrate, pH 6.0 for 45 min (for membrane-bound and soluble
CD100, CD72 and CD45) and for 25 min (for CD68, used as a
macrophage marker). To block non-specific background,
sections were incubated for 1 h at room temperature (RT) with
normal horse serum diluted 1:75 (for membrane-bound and
soluble CD100, CD72 and CD68); or with normal goat serum
diluted 1:75 (for CD45) (Vector Laboratories, Burlingame, CA,
USA). Sections were then incubated with the primary antibody
(listed in Table 2), overnight at 4uC. In particular, we used two
CD100 antibodies, one identifying only the (free) soluble form
and another identifying the (membrane-bound) intracytoplasmic
portion of CD100, which recognizes both the native and the
truncated form. After several washes in 50 mM Tris/HCl,
pH 7.6, slides were incubated with biotinylated horse anti
mouse antibody (CD100, CD72 and CD68) or biotinylated goat
anti rabbit antibody (CD45) diluted 1:200 for 1 h at RT (both
from Vector Laboratories). The peroxidase ABC method
(Vector Laboratories) was applied for 1 h at RT using 39,39
diaminobenzidine hydrochloride (DAB; Sigma, St Louis, MO,
USA) as the chromogen. Sections were counterstained in
Mayer’s hematoxylin, dehydrated and mounted with Eukitt
solution (Kindler GmbH and Co., Freiburg, Germany). For
negative controls, the primary or the secondary antibody was
omitted. Further negative controls were performed using non-
immune murine or rabbit serum.
Table 2. Antibodies used in the study.
Antibody Specificity
Ab dilution
for IH
{
mg of Ab/sample
for IP
1
Ab dilution
for WB
I Reference
mAb
* MCA1269 Human soluble CD100 1:50 2 mg 1:1000 AbD Serotec, Oxford, UK
mAb 610670 Human membrane-bound
CD100
1:5 / 1. 500 BD Transduction Laboratories
TM, Milan,
Italy
mAb MCA2501 Human CD72 1:25 2 mg 1:1000 AbD Serotec, Oxford, UK
Rabbit pAb
{ ab10558 Human CD45 1:10 / 1:500 Abcam, Cambridge, UK
mAb A5316 Human b-actin / / 1:5000 Sigma-Aldrich, Milan, Italy
mAb M 0814 Human CD68 1:80 / / DAKO Cytomation, Glostrup, Denmark
*mAb, monoclonal antibody;
{pAb, polyclonal antibody;
{IH, immunohistochemistry;
1IP, immunoprecipitation;
IWB, western blotting.
doi:10.1371/journal.pone.0035232.t002
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Tissue lysates of tonsil and miscarriage, term and first trimester
placenta were obtained after complete potter homogenization
(Ultra-Turrax T8, IKAH-WERKE, Lille, France) in cold lysis
buffer containing 20 mM Tris/HCl, pH 8.0, 1% NP-40, 137 mM
NaCl, 1 mM CaCl2, 1 mM MgCl2,10% glycerol, 5 mM EGTA,
10 mM EDTA, and freshly added protease inhibitors (Protease
Inhibitor Cocktail, Sigma, Milan, Italy). Extracts were cleared by
Figure 1. Quantitative RT-PCR of normal pregnancy and miscarriage placenta. Data are expressed as ‘‘fold changes’’ in relative gene
expression measured in miscarriage and term placentas compared with control tissue (first trimester placenta). mRNA expression profiles of a) CD100,
b) CD72 and c) CD45 show transcript down-regulation in pregnancy at term (p,0.001) and the highest values in second miscarriage placenta
(p.0.05). MC=miscarriage. Asterisks indicate the significance level: low (*), medium (**), high (***).
doi:10.1371/journal.pone.0035232.g001
Figure 2. Tissue from a representative first miscarriage, 9
th week of gestation. Paraffin serial sections. A subpopulation of Hofbauer cells
residing in the villous stroma, identified by CD68 (panel b,d,f), are positive for CD100 (panel a, red asterisks), CD72 (panel c, red asterisk) and CD45
(panel e, red asterisks). a,b,c,d,e,f,: Bar=60 mm.
doi:10.1371/journal.pone.0035232.g002
CD100, CD72, and CD45 in Human Miscarriage
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with the Bradford protein assay (Bio-Rad Laboratories) [33].
Samples were then immunoprecipitated for analysis of expression
of soluble CD100 and CD72, or directly subjected to western
blotting for quantitative determination of membrane-bound
CD100 and CD45.
Immunoprecipitation
Immunoprecipitation was performed using a 50% slurry of
washed GammaBind G Sepharose beads (GE Healthcare Bio-
Sciences AB, Uppsala, Sweden) in homogenization buffer; 2 mgo f
specific antibody (see Table 2) was added to 50 ml of the bead
suspension on ice, using a microcentrifuge tube for each sample.
Incubation was carried out overnight at 4uC under rotary
agitation. The beads were washed five times with lysis buffer to
remove unbound antibody, then gently resuspended in 50 ml of the
same buffer, and finally pipetted into a test tube containing 2 mg
of protein extract (the protein concentration of samples was
equalized to 2 mg/ml with lysis buffer). The lysate-beads mixture
was incubated overnight at 4uC under rotary agitation and
subsequently centrifuged at 1,0006g for 2 min to remove the
unbound fraction. The beads were then washed three times with
1 ml of homogenization buffer and centrifuged at 13,0006g for
2 min to remove any residual supernatant. Bound proteins were
eluted from the beads by incubation with 40 ml glycine 100 mM,
pH 2.5, for 30 min, under agitation at RT. Elutes were
neutralized with NaOH 0.1 M.
Western Blotting
Immunoprecipitated proteins (soluble CD100 and CD72) or
100 mg of tissue extract (membrane-bound CD100 and CD45)
were denatured in 1X loading denaturing buffer [34]. Samples
were boiled for 5 min and fractionated on 10% sodium dodecyl
sulphate - polyacrylamide gel electrophoresis (SDS-PAGE). All
blots, except membrane-bound CD100 blots, were incubated with
5% bovine serum albumin (BSA, Sigma) in TBS-T 0.1%;
membrane-bound CD100 blots were incubated with 5% non-fat
dry milk (Bio-Rad Laboratories) in TBS-T 0.1%; then all blots were
incubated overnight with the antibodies listed in Table 2. After
washing, blots were treated with appropriate secondary antibodies
conjugated to horseradish peroxidase and processed with the ECL-
Western blotting detection kit (both from Amersham Italia srl,
Milan, Italy) according to the manufacturer’s instructions.
The levels of CD100, CD72 and CD45 were assessed in at least
three separate experiments per molecule by densitometric analysis
using Bio-Rad’s ChemiDoc and Quantity-One software. Relative
quantities were expressed as the ratio of the densitometric reading
of each protein to the b-actin content of each sample.
Figure 3. Representative first trimester placenta (control). Paraffin serial sections of representative first trimester placenta (9
th week of
gestation) from a voluntary termination of pregnancy. A subpopulation of Hofbauer cells, identified by CD68 (panel b), are positive for CD100 (panel
a, red asterisks). Staining for CD72 (panel c) and CD45 (panel d) is largely negative. a,b,c,d: Bar=60 mm.
doi:10.1371/journal.pone.0035232.g003
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Results were expressed as mean + sd (for gene expression) or
mean 6 sd (for protein expression). A two-tailed t test (PRISM
software, version 4 for Windows: GraphPad Software Inc, San
Diego, CA) was used to analyze gene and protein expression data.
The significance level was considered as low (p#0.05), medium
(p#0.01) or high (p#0.001).
Results
CD100 Expression
Q-PCR analysis was applied to establish whether CD100 is
transcribed in placental tissue. As shown in Fig. 1a, CD100
mRNA levels never showed significant differences: differences
among the four miscarriage groups and differences between any of
the miscarriage groups and first trimester or term placenta were
Figure 4. Positive and negative control tissue. Tonsil tissue was used as a positive control for CD100 (panel a), CD45 (panel b), CD72 (panel c)
and CD68 (panel d). A positive reaction for CD100 (panel a, see inset), CD45 (panel b, see inset) and CD72 (panel c, see inset) was detected in
lymphocytes, and a positive reaction for CD68 was seen in macrophages (panel d, see inset). Negative control is shown in panel e. a,b,c,d,e:
Bar=30 mm; insets: Bar=300 mm.
doi:10.1371/journal.pone.0035232.g004
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the 3 w.g. subgroups (not shown). In contrast, CD100 transcripts
showed highly significant down-regulation in term compared with
first trimester placenta.
Immunostaining for soluble CD100 was negative in all placenta
samples (not shown). Membrane-bound CD100 was expressed in a
subpopulation of Hofbauer cells [Fig. 2a, 3a], identified using
CD68 [Fig. 2b, 3b], although these cells were scarcely detectable
in first trimester placenta [Fig. 3a]. The positive control (tonsil) for
membrane-bound CD100 and for CD68 yielded a positive result
on immunohistochemistry [Fig. 4a, d], confirming the quality of
the method used.
Analysis of western blots failed to disclose soluble CD100
expression in miscarriage, first trimester or term placenta (not
shown), whereas membrane-bound CD100 (either the native and
the truncated form) was expressed in all samples. The relative
abundance of membrane-bound CD100 protein made it possible
to analyze its expression by directly loading the protein extracts
onto SDS-PAGE, skipping the immunoprecipitation step. Western
blot analysis [Fig. 5] revealed that the expression of native CD100
was significantly (p,0.01) lower in first trimester placenta
compared with first and second miscarriage and with term
placenta [Fig. 5, 6a], and changed with w.g. [Fig. 5, 6b]. When
comparisons were made on the basis of w.g., differences were
more significant [Fig 5, 6c]. In first trimester placenta and in all
miscarriage groups, native CD100 protein expression peaked
between the 9
th and the 10
th week of pregnancy [Fig. 5, 6b].
The truncated form of CD100 was expressed in placenta
specimens and shared a very similar expression profile with native
CD100 (not shown).
Tonsil, used as a positive control, showed a strong signal for
membrane-bound CD100 on western blotting [Fig. 5].
CD72 Expression
Q-PCR analysis showed very similar expression profiles for
CD72 mRNA [Fig. 1b] and protein [Fig. 7, 8a]. However, there
were no significant differences in mRNA levels among miscarriage
groups or between any of these four groups and first trimester or
term placenta. As in the case of CD100, even when comparisons
were made with each of the 3 w.g. subgroups, differences were not
significant (not shown). In contrast, CD72 transcripts were highly
significantly down-regulated in term compared with first trimester
placenta [Fig. 1b].
CD72 immunostaining was detected in all four miscarriage
groups, in a subpopulation of Hofbauer cells [Fig. 2c], identified
using CD68 [Fig. 2d], but not in first trimester placenta [Fig. 3c].
Western blot analysis documented CD72 expression [Fig. 7] in
all placenta samples. It was significantly (p,0.05) increased in first
miscarriage compared with first trimester placenta, and signifi-
cantly (p,0.01) decreased in third miscarriage compared with first
miscarriage [Fig. 7, 8a]. When comparisons were made on the
basis of w.g. [Fig.7, 8b], differences among placental groups were
more significant [Fig. 7, 8c]. Interestingly, CD72 expression
peaked between the 9
th and the 10
th w.g. in several sample groups
(first trimester placenta and first, second and third miscarriage)
[Fig.7, 8b].
Tonsil, used as a positive control, exhibited strong CD72 and
CD68 protein expression on immunohistochemistry [Fig. 4b, d]
and western blotting [Fig. 7].
Figure 5. Native CD100 protein expression in normal pregnancy and in miscarriage. Representative immunoblot. MC=miscarriage. 8–9
weeks (8# w.g. ,9); 9–10 weeks (9# w.g. #10); .10 weeks (w.g. .10). b-actin: housekeeping protein. nCD100: native CD100.
doi:10.1371/journal.pone.0035232.g005
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Q-PCR analysis showed very similar expression profiles for
CD45 mRNA [Fig. 1c] and protein [Fig. 9, 10a] except in term
placentas, where transcript levels were considerably lower. The
differences in mRNA levels among the four miscarriage groups
and differences between any of the miscarriage groups and first
trimester or term placenta were not significant, even when
comparisons were made with each of the 3 w.g. subgroups (not
shown). In contrast, CD45 transcripts were highly significantly
down-regulated in term compared with first trimester placenta
[Fig. 1c].
In miscarriage placenta, CD45 immunopositivity was detected
in a subpopulation of Hofbauer cells [Fig. 2e] identified by CD68
[Fig. 2f] and in syncytiotrophoblasts, whereas most specimens
from normal first trimester pregnancies showed no macrophage
reactivity and weak heterogeneous syncytial staining [Fig. 3d].
Since CD45 protein is abundant in placenta, its expression was
analyzed by directly loading the protein extracts onto SDS-PAGE,
as in the case of CD100. Representative western blots are shown in
Fig. 9. CD45 expression was significantly (p,0.01) lower in first
trimester than in second miscarriage and term placenta [Fig. 9,
10a]. As in the case of both CD100 and CD72, its expression
changed markedly with w.g. [Fig. 9, 10b]. When comparisons
were made on the basis of w.g., differences were more significant
[Fig 9, 10c]. In first trimester placenta and in all miscarriage
groups, CD45 protein expression peaked between the 9
th and the
10
th week of pregnancy [Fig. 9, 10b].
Tonsil, used as a positive control, revealed strong CD45 and
CD68 expression on immunohistochemistry [Fig. 4c, d] and
western blotting [Fig. 9].
Discussion
To the best of our knowledge, this is the first study investigating
the expression of CD100, CD72 and CD45 mRNA and protein in
placenta from miscarriage, the commonest complication of
pregnancy. The three molecules are known to play a role in the
Figure 6. Densitometric analysis of native CD100 protein expression relative to b-actin in normal pregnancy and in miscarriage. a)
Native CD100 protein expression is significantly (p,0.01) lower in the first trimester of gestation than at term as well as in first trimester vs first and
second miscarriage (both p,0.01). Its expression level is highest in first and second miscarriage and decreases subsequently. b) In the first trimester
and in all miscarriage groups, native CD100 expression increases from the 8
th to the 10
th week of gestation; these differences are significant only for
third (p,0.01) and fourth (p,0.05) miscarriage. A reduction in native CD100 expression after the 10
th week is significant for first trimester and for
third miscarriage (both p.0.05). Different levels of native CD100 are seen in all miscarriage groups between the 8# w.g. ,9 and the w.g. .10
subgroups, but not in first trimester. c) In all weeks of gestation, native CD100 expression is significantly lower in first trimester vs first and second
miscarriage (both p,0.001). Before the 9
th week of pregnancy, it is significantly greater in second vs third and fourth miscarriage (both p,0.001).
Between the 9
th and the 10
th week, native CD100 expression is significantly lower in first trimester placenta vs third and fourth miscarriage (both
p,0.01), and significantly higher in second and third miscarriage vs fourth miscarriage (both p,0.05). After the 10
th week, its expression is
significantly lower in first trimester vs fourth miscarriage (p,0.001). MC=miscarriage. Asterisks indicate the significance level: low (*), medium (**),
high (***). 8–9 weeks (8# w.g. ,9); 9–10 weeks (9# w.g. #10); .10 weeks (w.g. .10).
doi:10.1371/journal.pone.0035232.g006
Figure 7. CD72 protein expression in normal pregnancy and in miscarriage. Representative immunoblot. MC=miscarriage. 8–9 weeks (8#
w.g. ,9); 9–10 weeks (9# w.g. #10); .10 weeks (w.g. .10). b-actin: housekeeping protein.
doi:10.1371/journal.pone.0035232.g007
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factor in miscarriage. We found similar CD100, CD72 and CD45
mRNA and protein profiles, but different expression levels, in
miscarriage compared to normal pregnancy. The western blotting
data were confirmed by the immunohistochemical findings. In
particular, tissue from the majority of normal first trimester
pregnancies showed no CD100 and CD72 staining and weak
heterogeneous syncytial staining for CD45, whereas in all
miscarriage groups the three molecules were expressed by
subpopulations of Hofbauer cells (placental macrophages) residing
in the villous placental stroma. Absence of native CD100, which is
normally expressed by macrophages, results in reduced macro-
phage recruitment; therefore, the CD100 found in Hofbauer cells,
independently of its effects on the adaptive immune response,
could have a role in macrophage recruitment, as described in
other organs [35]. We also found that part of the CD100 expressed
by Hofbauer cells was cleaved from their surface, giving rise to the
soluble form [30]. This form results from phosphorylation of
cytoplasmic CD100, which is associated to serine and/or
threonine kinase activities [36]. CD100 and CD45 form a
functional association in immune cells; their levels increase during
immune system activation [28], promoting the maturation and
differentiation of these cells [29]. CD45 is endowed with intrinsic
protein tyrosine phosphatase (PTPase) activity [37], which is
responsible for initial activation of the serine and/or threonine
kinase associated to CD100. CD45 was abundant in placental
macrophages and in syncytiotrophoblasts from miscarriage tissue
and shared a similar expression profile with CD100. This finding
corroborates the production of the soluble CD100 form, which is
immediately shed from placental tissue, as shown by its absence in
placental villi of all samples. Moreover, since soluble CD100
release from the immune cell surface is well regulated and strictly
dependent on cell activation [38], this form enhances the immune
response by acting on remote immune cells in a similar manner to
other diffusible factors, such as cytokines and chemokines. CD100
could therefore be involved in immune response stimulation in
miscarriage, supporting the hypothesis of high levels of fetal
immune system activity during pregnancy loss [18]. It is thus
Figure 8. Densitometric analysis of native CD72 protein expression relative to b-actin in normal pregnancy and in miscarriage. a)
CD72 is more abundant in first and second miscarriages and absent in term placenta. Significant differences in CD72 expression are detected only in
first trimester vs first miscarriage (p,0.05) and in first vs third miscarriage (p,0.01). b) In first trimester and in first, second and third miscarriage,
CD72 expression shows a significant increase from the 8
th to the 10
th week of gestation and subsequently a significant reduction after the 10
th week
(both p,0.001). Similar CD72 expression levels are found in first trimester and in first, second and third miscarriage between the 8# w.g. ,9 and the
w.g. .10 subgroups. c) Trend of CD72 expression in first trimester and in the four miscarriage groups at approximately the same gestational week.
Before the 9
th and after the 10
th week, CD72 expression is significantly greater in first miscarriage vs first trimester (p,0.001) and significantly lower in
second, third and fourth miscarriage vs first miscarriage (p,0.001). Between the 9
th and the 10
th week, CD72 expression is significantly lower in first
trimester vs first and second miscarriage (both p,0.001) and significantly higher in second miscarriage vs third and fourth miscarriage (both
p,0.001). MC=miscarriage. Asterisks indicate the significance level: low (*), medium (**), high (***). 8–9 weeks (8# w.g. ,9); 9–10 weeks (9# w.g.
#10); .10 weeks (w.g. .10).
doi:10.1371/journal.pone.0035232.g008
Figure 9. CD45 protein expression in normal pregnancy and in miscarriage. Representative immunoblot. MC=miscarriage. 8–9 weeks (8#
w.g. ,9); 9–10 weeks (9# w.g. #10); .10 weeks (w.g. .10). b-actin: housekeeping protein.
doi:10.1371/journal.pone.0035232.g009
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constitute a reservoir of soluble CD100, enabling a stronger
immune response [39]. A role for CD45 in fetal immunotolerance
may also be hypothesized. The present findings suggest that high
CD45 expression could be associated to fetal rejection of maternal
cells. Excessive amounts of CD45 protein in placenta tissue
probably enhance release of soluble CD100, which fetal mecha-
nisms are unable to break down. Interestingly, soluble CD100
levels in the sera of patients with autoimmune diseases correlate
with autoantibody titre, suggesting that its determination could
help monitor disease activity [38].
These data lend support to the hypothesis that soluble CD100 is
released in maternal blood and acts on maternal cells. Notably,
CD45 expression was higher in term compared with first trimester
placenta despite exhibiting lower mRNA levels in the former
specimens. Increased CD45 protein expression at the end of
pregnancy is an index of strong fetal immune system activation;
high activation levels may exceed immunotolerance by the fetus,
precipitating labor. CD72 immunostaining was also detected in a
subpopulation of Hofbauer cells. The molecule functions as a
negative regulator, blocking immune cell responses in normal
conditions. Immune activation by soluble CD100 turns off its
inhibitory signal [26]. Interestingly, CD72 protein was higher in
first trimester than in term placentas, as shown by western blot
analysis, suggesting its involvement in pregnancy maintenance.
The almost overlapping expression patterns of CD72 and CD45
proteins found in all miscarriage groups suggest a link between
CD45 over-expression and CD72 up-regulation.
The expression of CD100, CD72 and CD45 seemed to be finely
regulated, because small gestational week increments induced
strong changes. An outstanding question is why their expression
was most altered in first and second miscarriage placenta
compared with third and fourth miscarriage tissue, particularly
around the 10
th w.g. It is indeed surprising that their levels
increase on this particular w.g., when progesterone production
switches from the corpus luteum to the placenta. The fact that
progesterone has a role in modulating macrophage activation [40]
suggests that it can exert an influence on macrophage expression
of CD100, CD72 and CD45 precisely on the 10
th week of
gestation.
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